Several supportive government initiatives and research collaborations benefitting key players in the global bioprocess technology market, says Fact.MR.

ROCKVILLE PIKE SUITE, ROCKVILLE, INDIA, June 18, 2024 /EINPresswire.com/ --
Fact.MR, a market research and competitive intelligence provider, reveals in its updated research report that the global bioprocess technology market (バイオプロセス技術市場) is valued at US$ 30.7 billion in 2024 and has been forecasted to increase at a CAGR of 14.8% from 2024 to 2034.

Governments across the world are investing heavily in the expansion of their healthcare facilities. This is generating high-growth opportunities for bioprocess technology providers. Individuals who are keen on accessing treatment alternatives for chronic disorders are also set to open profitable opportunities for key market players. Considering these dynamics, industry giants are investing in research and development activities for the development of cell-level and DNA-level treatment options.

Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=6882

Stainless steel bioreactors are expected to exhibit high demand growth in North America over the coming years. Europe is witnessing surging demand for monoclonal antibodies, antibiotics, and biosimilars. Rising cases of chronic disorders such as diabetes, cancer, and cardiovascular diseases are driving the need for innovative bioprocess technologies in Asia Pacific’s pharma sector.

Biopharmaceutical outsourcing is emerging as an effective strategy to meet the unmet needs of patients. This is increasing the demand for bioprocess technologies with advanced efficiency and reliability.

Key Takeaways from Market Study

Global sales of bioprocess technologies are poised to soar, reaching US$ 121.9 billion by 2034. In 2024, the United States leads the charge with a market value estimated at US$ 3.3 billion, highlighting its pivotal role in driving technological advancements in bioprocessing. Canada, meanwhile, is projected to command a substantial 33.6% share of the North American market by 2024, underlining its growing prominence in the biotechnology sector. South Korea emerges as a dynamic player, with demand for bioprocess technologies expected to surge at an impressive CAGR of 15.6% through 2034, driven by robust investments in healthcare and biopharmaceutical research. Biopharmaceuticals are anticipated to dominate the market landscape, capturing 32.9% of the global market share by 2034, fueled by increasing R&D activities and rising healthcare demands worldwide. Moreover, the market for bioprocess technologies in research labs is set to achieve a significant milestone, reaching a valuation of US$ 13 billion by 2024, underscoring the critical role of innovative bioprocessing solutions in advancing scientific research and development.

“Rising need for personalized medicines for the treatment of chronic disease is driving the use of bioprocess technologies for drug production,” says a Fact.MR analyst.

Cell Culture Bioprocess Technologies Holds Promise to Develop Effective Solutions for Early Detection of Critical Diseases

Crohn’s disease is a life-threatening health condition. Lack of research on this disease is creating opportunities for leading companies in this market. Cell-level treatment has shown promising results if treated at the foundation level. Cell culture technology can detect early systems of chronic disorders and aid in reducing their severity.

Increasing prevalence of contagious diseases is also driving the use of cell culture bioprocess technologies in drug production. Vaccines for diseases such as rubella, smallpox, hepatitis, rotavirus, polio, and chickenpox are being manufactured using cell culture technology.

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global bioprocess technology market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).

The study divulges essential insights on the market based on type (cell culture, cell expansion, flow cytometry, cell line development, virus infiltration), application (biopharmaceuticals, specialty products, industry chemicals, environment management aids), and end user (hospitals, research labs, medical institutions, others), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=6882

Explore More Related Studies Published by Fact.MR Research:

3D Cell Culture Market: (3D細胞培養市場) The global 3D cell culture market size is estimated at US$ 572.8 million in 2024 and is forecasted to reach US$ 1.42 billion by 2034-end, advancing at a CAGR of 9.5% between 2024 and 2034.

Mammalian Cell Banking Market: (哺乳類細胞バンキング市場) The mammalian cell banking market size is on track to reach US$ 499.7 million in 2024. The market is poised for rapid growth, with an extraordinary compound annual growth rate (CAGR) of 14.0% projected through 2034. This expansion is anticipated to elevate the market to a substantial valuation of US$ 1,845.6 million by 2034.

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com

Akshay Gorde
FactMR
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.